Genome Editing to Abrogate Muscle Atrophy

Area of Science:

• Biomedical research
• Molecular biology
• Genetics

Background:

• Muscle atrophy is a complex condition that diminishes patient quality of life and increases mortality in chronic diseases.
• Current treatments for muscle atrophy are limited, with exercise being the primary intervention.
• Genome editing technologies are rapidly advancing, showing potential for treating various diseases.

Approach:

• Systematic review of muscle atrophy etiology and signaling pathways.
• Evaluation of genome editing applications for muscle atrophy treatment.
• Discussion of the potential and challenges of using gene editing for muscle wasting.

Key Points:

• Muscle atrophy is a multifactorial syndrome with severe consequences.
• Existing treatments for muscle atrophy are insufficient.
• Genome editing presents a novel therapeutic strategy for muscle atrophy.

Conclusions:

• Genome editing holds significant promise for developing effective treatments for muscle atrophy.
• Further research into genome editing applications is crucial for clinical translation.
• This review highlights the potential of gene editing to address unmet needs in muscle atrophy management.